Frontlight ResearchEarly access
Colorectal cancer trials in Italy
157 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Avellino, Aviano, Bari, Castellana Grotte, Catania, La Spezia, Milan, Milano, Naples, Padova, Pisa, Ravenna, Reggio Emilia, San Giovanni Rotondo, Tricase
- Age
- 18 years and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - Phase 2Not yet taking people in ItalyA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Milan, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - Phase 3Taking peopleRandomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer (IMPROVE-2 trial)
- Where
- Ancona, Avellino, Bari, Bergamo, Brescia, Caserta, Castellana Grotte, Catania, Catanzaro, Firenze, Foggia, Frattamaggiore, Genoa, Lecce, Legnano, Località la Schiana, Pozzuoli (NA), Milan, Milano, Mirabella Eclano, Naples, Padova, Palermo, Pavia, Pescara, Peschiera del Garda, Pisa, Potenza, Ragusa, Reggio Emilia, Roma, Rome, San Giovanni Rotondo, Sassari, Statte, Teramo, Torino, Tricase, Verona, A.O.U Maggiore della Carità
- Age
- 18 years and over
- People
- 500
- Run by
- IRCCS Istituto Nazionale Tumori Fondazione Pascale
See details and how to join2023-509551-14-00 - Phase 2Taking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Where
- Milan
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06607458 - Phase 1/2Taking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Milan, Pisa, Roma
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - Phase 3Taking peopleA Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)
- Where
- Aviano, Bologna, Brescia, Cagliari, Candiolo, Catania, Florence, Genoa, Meldola, Milan, Naples, Orbassano, Padova, Pisa, Rome, Rozzano, San Giovanni Rotondo, Verona
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Summit Therapeutics Inc.
See details and how to join2025-521587-35-00 - Phase 4Taking peopleA biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial
- Where
- Aviano, Catania, Florence, Livorno, Meldola, Milan, Modena, Monserrato, Padova, Pisa, Ravenna, Rome, San Giovanni Rotondo, Tricase, Ospedale di Prato Santo Stefano
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Fondazione GONO G.I.
See details and how to join2025-521209-42-00 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Bologna, Candiolo, Naples, Rozzano, Verona
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - No phaseTaking peopleStigma and Psychological profilE in REctal-anal caNcer pAtients
- Where
- Roma
- Age
- 18 years to 75 years
- People
- 148
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06366841 - Phase 1/2Not yet taking people in ItalyPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 2Taking peopleSTREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
- Where
- Avellino, Caserta, Località la Schiana, Pozzuoli (NA), Naples, Napoli, Potenza, San Giovanni Rotondo, Tricase
- Age
- 18 years and over
- People
- 60
- Run by
- National Cancer Institute, Naples
See details and how to joinNCT07213570 · EU 2024-519669-23-00 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Where
- Florence, Naples, Rozzano
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- AbbVie
See details and how to joinNCT07023289 · EU 2024-518015-19-00 - Phase 3Taking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Florence, Milan, Naples, Padova, Pisa, Rome, Tricase, Udine
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - Phase 2Taking peopleTemozolomide and irinotecan consolidation in patients with MGMT silenced, microsatellite stable colorectal cancer with persistence of minimal residual disease in liquid biopsy after standard adjuvant chemotherapy: the ERASE-TMZ study
- Where
- Ancona, Aviano, Brescia, Candiolo, Catania, Cremona, Cuneo, Faenza, Florence, Genoa, Meldola, Milan, Modena, Monserrato, Monza, Naples, Padova, Pisa, Prato, Reggio Emilia, Rome, Tricase, Turin, Udine, Vicenza
- Age
- 18 years and over
- People
- 25
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-515681-14-00 - Phase 1Not yet taking people in ItalyA Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Where
- Roma
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Bayer
See details and how to joinNCT07535112 · EU 2025-523648-11-00 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Ancona, Bologna, Florence, Milan, Naples, Ravenna
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 2Taking peoplePhase II study of adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the prevention of peritoneal metastases after curative-intent surgery for high-risk colorectal cancer.
- Where
- Milan
- Age
- 18 years and over
- People
- 30
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-513376-17-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Milan, Naples
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Ancona, Aviano, Meldola, Milan, Naples, Orbassano, Ravenna, Verona
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 2/3Taking peopleNeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced rectal cancer. A multi-arm, multi-stage, intergroup (STAR-04/SICO-CR01/GISCAD/AIRO-GI) randomised clinical trial. The NeoAspMet trial
- Where
- Aviano, Bari, La Spezia, Milan, Modena, Monserrato, Monza, Naples, Novara, Orbassano, Padova, Palermo, Pinerolo, Ponderano, Potenza, Ragusa, Reggio Emilia, Rome, Sondrio, Statte, Taormina (Italy), Treviglio, Turin, Udine
- Age
- 18 years and over
- People
- 340
- Run by
- IRCCS Istituto Nazionale Tumori Fondazione Pascale
See details and how to join2024-519007-10-00 - Phase 1/2Taking peopleA Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609 - Phase 2Taking people[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Bergamo, Milan, Monza, Rome
- Age
- 18 years to 79 years
- People
- 71 worldwide
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07702292 · EU 2025-521983-36-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Meldola, Reggio Emilia, Roma
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 2Taking peoplePre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
- Where
- Milan
- Age
- 18 years and over
- People
- 197
- Run by
- Gruppo Oncologico del Nord-Ovest
See details and how to joinNCT05845450